PhRMA, the pharmaceutical marketing and research trade association, announced a list of drugs in varying stages of development for treating psychiatric disorders. Although the announcement specifies 301 drugs, the number of new agents is actually less. Many of the drugs, including Zyprexa, Concerta, Zoloft, Seroquel, are already available but the clinical studies and applications are pending for new uses. The 32-page report is available from PhRMA.